Gregory W. Daniel, PhD, MPH, RPh
Articles
February 13th 2019
Value-Based Arrangements May Be More Prevalent Than Assumed
Nirosha Mahendraratnam, PhD Corinna Sorenson, PhD, MHSA, MPH Elizabeth Richardson, MSc Gregory W. Daniel, PhD, MPH, RPh Lisabeth Buelt, MPH Kimberly Westrich, MA Jingyuan Qian, MPP Hilary Campbell, PharmD, JD Mark McClellan, MD, PhD Robert W. Dubois, MD, PhD
We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 1st 2024 | Updated: November 21st 2024
Table Multiple Myeloma Trials November 2024
